Latest Novartis Stories
GAITHERSBURG, Md., Nov. 12, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the three-month and nine-month periods ended September 30, 2014.
Campaign Secures 3 Million Life-Saving Malaria Treatments in Advance of Three Year Goal Using Tech Tools to Mobilize Global Public NEW YORK, Nov.
Global Herbicides Market 2014-2018 and Global Fungicides Market 2014-2018 are new research reports added to Sandlerresearch.org store. Dallas, Texas (PRWEB)
HILDEN, Germany, and MANCHESTER, England, November 11, 2014 /PRNewswire/ -- - Master collaboration agreement is a framework for developing and
GAITHERSBURG, Md., Nov. 5, 2014 /PRNewswire/ -- GenVec, Inc.
AUSTIN, Texas, Nov. 4, 2014 /PRNewswire/ -- XBiotech announced today that Dr. Daniel Vasella has joined the Company as a member of the Board of Directors. Dr.
- Results show 94% of patients made lifestyle modifications as a result of their NET, including changes to diet, work, physical activities and social life(1) EAST HANOVER, N.J., Nov.
GAITHERSBURG, Md., Oct. 31, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc. appointed Quinterol J. Mallette, M.D.